Transamerica Financial Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Buy
326
+146
+81% +$9.73K ﹤0.01% 849
2026
Q1
$11.3K Buy
180
+76
+73% +$5.29K ﹤0.01% 895
2025
Q4
$6.91K Hold
104
﹤0.01% 908
2025
Q3
$6.97K Buy
104
+48
+86% +$3.8K ﹤0.01% 802
2025
Q2
$4.81K Sell
56
-25
-31% -$1.96K ﹤0.01% 362
2025
Q1
$6K Sell
81
-10
-11% -$816 ﹤0.01% 356
2024
Q4
$8K Sell
91
-13
-13% -$962 ﹤0.01% 342
2024
Q3
$7K Sell
104
-47,896
-100% -$3.93M ﹤0.01% 338
2024
Q2
$5.44M Hold
48,000
0.58% 43
2024
Q1
$6.66M Buy
48,000
+43,635
+1,000% +$5.48M 0.68% 29
2023
Q4
$542K Buy
+4,365
New +$446K 0.07% 171

Other funds holding DXCM

Transamerica Financial Advisors's DXCM Position: Q2 2026 in Review

Transamerica Financial Advisors increased its DexCom (DXCM) stake by 81% in Q2 2026, buying an estimated $9.73K and bringing the position to 326 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Transamerica Financial Advisors first reported a position in DXCM in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.66M in Q1 2024. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Transamerica Financial Advisors held 326 shares of DexCom worth $22K as of Q2 2026.
  • Transamerica Financial Advisors bought 146 DexCom shares in Q2 2026, an estimated $9.73K.
  • DexCom made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #849 holding.
  • Transamerica Financial Advisors first reported a position in DexCom in Q4 2023 and has held it in 11 quarters since.
  • Transamerica Financial Advisors's DexCom position peaked at $6.66M in Q1 2024.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.